Abeona Therapeutics Inc. Stock
Price
Target price
€5.30
€5.30
-1.850%
-0.1
-1.850%
€16.16
12.08.25 / Stuttgart Stock Exchange
WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Abeona Therapeutics Inc. Stock
We can see a decrease in the price for Abeona Therapeutics Inc.. Compared to yesterday it has lost -€0.100 (-1.850%).
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 16 € there is potential for a 201.89% increase which would mean more than doubling the current price of 5.3 € for Abeona Therapeutics Inc..
Our community identified positive and negative aspects for Abeona Therapeutics Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abeona Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | -1.850% | -4.505% | 8.607% | 33.838% | 0.952% | 14.520% | -91.544% |
| Krystal Biotech | 0.800% | 3.665% | -2.957% | -27.081% | -19.152% | 52.857% | - |
| Ardelyx Inc. | 2.710% | 8.219% | 24.915% | -10.041% | -3.464% | 437.513% | 0.863% |
| Evolus Inc | -3.610% | -36.842% | -40.000% | -59.664% | -54.286% | -48.387% | 50.094% |
Comments
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $19.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its price target lowered by analysts at Stifel Nicolaus from $21.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ABEO provided by MarketBeat